Biogen, Inc. (BIIB)
254.51
+5.58
(+2.24%)
USD |
NASDAQ |
Nov 04, 16:00
254.51
0.00 (0.00%)
After-Hours: 16:28
Biogen Total Return Price : 254.51 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 248.93 |
| November 02, 2026 | 249.01 |
| October 30, 2026 | 253.62 |
| October 29, 2026 | 249.65 |
| October 28, 2026 | 244.05 |
| October 27, 2026 | 252.73 |
| October 26, 2026 | 252.26 |
| October 23, 2026 | 250.69 |
| October 22, 2026 | 253.84 |
| October 21, 2026 | 240.98 |
| October 20, 2026 | 243.10 |
| October 19, 2026 | 233.48 |
| October 16, 2026 | 232.65 |
| October 15, 2026 | 235.35 |
| October 14, 2026 | 232.83 |
| October 13, 2026 | 228.90 |
| October 12, 2026 | 229.41 |
| October 09, 2026 | 225.71 |
| October 08, 2026 | 218.43 |
| October 07, 2026 | 222.15 |
| October 06, 2026 | 222.89 |
| October 05, 2026 | 223.59 |
| October 02, 2026 | 219.88 |
| October 01, 2026 | 222.82 |
| September 30, 2026 | 225.88 |
| Date | Value |
|---|---|
| September 29, 2026 | 227.07 |
| September 28, 2026 | 228.69 |
| September 25, 2026 | 227.60 |
| September 24, 2026 | 226.36 |
| September 23, 2026 | 227.53 |
| September 22, 2026 | 225.36 |
| September 21, 2026 | 219.07 |
| September 18, 2026 | 215.50 |
| September 17, 2026 | 219.05 |
| September 16, 2026 | 216.01 |
| September 15, 2026 | 216.17 |
| September 14, 2026 | 217.36 |
| September 11, 2026 | 217.15 |
| September 10, 2026 | 215.43 |
| September 09, 2026 | 210.73 |
| September 08, 2026 | 212.50 |
| September 04, 2026 | 220.83 |
| September 03, 2026 | 224.51 |
| September 02, 2026 | 222.67 |
| September 01, 2026 | 216.04 |
| August 31, 2026 | 216.65 |
| August 28, 2026 | 218.50 |
| August 27, 2026 | 221.50 |
| August 26, 2026 | 221.07 |
| August 25, 2026 | 220.77 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| AbbVie, Inc. | 294.77 |
| Gilead Sciences, Inc. | 174.45 |
| Amgen, Inc. | 478.34 |
| Eli Lilly & Co. | 1417.82 |
| Regeneron Pharmaceuticals, Inc. | 930.74 |